Why I'd avoid Medibank Private Ltd at this share price

Is Medibank Private Ltd (ASX:MPL) an opportunity at today's prices?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Health insurers have recently been bid up to frothy multiples by the market. While some like NIB Holdings Limited (ASX: NHF) – a small insurer that has been rapidly claiming market share – deserve their day in the sun, Medibank Private Ltd (ASX: MPL) continues to puzzle me.

The Medibank share price has lifted around 16% this year after the company delivered 7.6% net profit growth at its annual report. However, I thought the company's results were mediocre, with the strong headline numbers masking several underlying problems:

  • The health insurance business is still going backwards. The company lost 0.6% market share this year and health insurance profits fell an amount equivalent to ~2% of net profit after tax (NPAT).
  • The lift in profits was almost entirely due to investment income. This year's investment income of $139 million reflects a 5.6% yield on Medibank's $2.5 billion portfolio – more than doubles last year's 2.4% yield.
  • Medibank has revised its equity allocation downwards (taking less risk) and I'm doubtful the company can achieve a 5.6% yield in 2018 in a portfolio that is 80% bonds and cash.
source: Company presentation

There were some surprise improvements, with a big lift in complementary services profit (now called Medibank Health) following divestments last year, and a huge reduction in complaints to the ombudsman. I give significant credit to management for their transparency.

source: Company presentation

I think there is a certain incoherence to some of the goals set above. For example Medibank may struggle to have a best-in-class Net Promoter Score (NPS; a reflection of how likely customers are to recommend the company's products), while simultaneously wanting to keep its margins and return on equity above those of peers.

This is because a higher NPS requires happier customers, and those usually require investment in customer service, product price, and the claims experience, which may also make it harder for Medibank to trim its claim expenses.

Likewise if the health insurance business is shrinking, and it is, it becomes much easier to double the Medibank Health share of operating profits.

On the topic of return on equity, Medibank generates more than 50% greater return than its peers do, for every dollar of equity in the business. That's usually suggestive of a solid competitive advantage.

However, can there really be a competitive advantage in a commoditised product like health insurance, especially if there are not-for-profit peers? There may be an advantage in scale and brand recognition, but if so Medibank's advantage is being eroded.

Should this stabilise for a few years, it would suggest to me that Medibank does have an advantage.  If it doesn't stabilise, well…

I think Medibank is a good business with a good CEO, and were it more modestly priced I would be looking at it as a possible turnaround. However, I think it's currently priced in a way that suggests only modest returns for shareholders, with the possibility of further downside due to market share losses and thinner profit margins. As a result I continue to avoid it.

Motley Fool contributor Sean O'Neill has no position in any of the stocks mentioned. The Motley Fool Australia has recommended NIB Holdings Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »